Madeline Jones-Ryan, endocrinologist, shares more about these medications and how they change the game for those managing type 2 diabetes
Unlike GHK-Cu, which has decades of preclinical and some cosmetic data, AHK-Cus peptide-specific evidence is essentially one ex-vivo / in-vitro study [1] , and no study of any kind has injected it
Metformin has been shown to have some anti-inflammatory effects in clinical studies in patients with T2DM, in experimental studies in rodent models of obesity and T2DM, and in vitro experiments with several immune cells (Foretz et al., 2019
Additionally, methylation plays a crucial role in epigenetic modifications, which can alter the expression of genes without changing the DNA sequence
You deserve a clear side-by-side, not a blurred one